Nestle Health Science CEO Greg Behar to Be Replaced By Anna Mohl
By David Sachs Nestle said Friday that Greg Behar, chief executive officer of its food sciences arm, will leave at the end of the year. The Swiss food...
Stay updated with breaking news from Greg Behar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By David Sachs Nestle said Friday that Greg Behar, chief executive officer of its food sciences arm, will leave at the end of the year. The Swiss food...
Greg Behar, the chief executive of Nestlé Health Science, has stepped down from the position. Anna Mohl will succeed Behar in the role.
Nestlé has divested Palforzia, its peanut allergy treatment business, to Stallergenes Greer, a biopharmaceutical company.
Peanut allergy treatment business divested to Stallergenes Greer.
Peanut allergy therapy Palforzia, which Nestlé acquired in a multi-billion dollar deal, has been sold to allergy product company Stallergenes Greer. Palforzia was the first FDA-approved drug for peanut allergy, but its sales were hampered by the Covid-19 pandemic.